Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in prostate cancer / / edited by Gertrude Hamilton
| Advances in prostate cancer / / edited by Gertrude Hamilton |
| Pubbl/distr/stampa | Rijeka, Croatia : , : IntechOpen, , [2013] |
| Descrizione fisica | 1 online resource (704 pages) : illustrations |
| Disciplina | 616.99463 |
| Soggetto topico | Prostate - Cancer - Treatment |
| ISBN | 953-51-7064-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910317759303321 |
| Rijeka, Croatia : , : IntechOpen, , [2013] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Androgen-responsive genes in prostate cancer : regulation, function and clinical applications / / edited by Zhou Wang
| Androgen-responsive genes in prostate cancer : regulation, function and clinical applications / / edited by Zhou Wang |
| Edizione | [1st ed. 2013.] |
| Pubbl/distr/stampa | New York, : Springer, 2013 |
| Descrizione fisica | 1 online resource (346 p.) |
| Disciplina | 616.994630695 |
| Altri autori (Persone) | WangZhou |
| Soggetto topico |
Prostate - Cancer - Genetic aspects
Prostate - Cancer - Treatment |
| ISBN |
1-299-33798-8
1-4614-6182-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface -- Roles of androgen receptor coregulators and cell signaling in regulation of androgen-responsive genes -- Selective and classical Androgen Response Elements in androgen-regulated gene expression -- Negative androgen-response elements in androgen target genes -- Chromatin looping and long distance regulation by androgen receptor -- The Functionality of Prostate Cancer Predisposition Risk Regions is revealed by AR Enhancers -- Mechanisms of ARE-independent Gene Activation by the Androgen Receptor in Prostate Cancer Cells: potential targets for better intervention strategies -- Androgen action, Wnt signaling, and prostate tumorigenesis -- Toward Revealing the Complexity of Androgen Responsive Protein and Non-coding Transcripts in Prostate Cancer -- Androgen-Responsive Gene Expression in Prostate Cancer Progression -- Androgen receptor regulated genes in prostate cancer initiation vs metastasis -- Androgen-Independent Induction of Androgen-Responsive Genes By Interleukin-6 Regulation -- The effect of AR overexpression on androgen signaling in prostate cancer -- The expression signature of androgen receptor splice variants and their distinctive transcriptional activities in castration-resistant prostate cancer -- Androgen regulation of the cell cycle in prostate cancer -- Androgen Receptor Signaling Interactions Control Epithelial-Mesenchymal Transition (EMT) in Prostate Cancer Progression -- Androgen receptor regulation of serum response factor signaling in prostate cancer -- Regulation of angiogenesis by androgen-responsive gene EAF2 -- The role of miR-21, an androgen-regulated microRNA, in prostate cancer -- Androgen dependent oncogenic activation of ETS transcription factors by recurrent gene fusions in prostate cancer: Biological and Clinical Implications -- Clusterin as a target for treatment of castration-resistant prostate cancer -- Index. |
| Record Nr. | UNINA-9910739436903321 |
| New York, : Springer, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
External radiation therapy [[electronic resource]]
| External radiation therapy [[electronic resource]] |
| Pubbl/distr/stampa | [Bethesda, Md.] : , : National Institutes of Health, , [between 2000 and 2009?] |
| Soggetto topico |
Prostate - Cancer - Radiotherapy
Prostate - Cancer - Treatment |
| Soggetto genere / forma |
Documentary films.
Streaming videos. |
| Formato | Videoregistrazioni  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910699156003321 |
| [Bethesda, Md.] : , : National Institutes of Health, , [between 2000 and 2009?] | ||
| Videoregistrazioni | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Image guided prostate cancer treatments / / Robert L. Bard, Jurgen J. Futterer, Dan Sperling, editors
| Image guided prostate cancer treatments / / Robert L. Bard, Jurgen J. Futterer, Dan Sperling, editors |
| Edizione | [1st ed. 2014.] |
| Pubbl/distr/stampa | Heidelberg, Germany : , : Springer, , 2014 |
| Descrizione fisica | 1 online resource (xiv, 268 pages) : illustrations (some color) |
| Disciplina |
610
616.07543 616.0757 616.99463 |
| Collana | Gale eBooks |
| Soggetto topico |
Prostate - Cancer - Treatment
Prostate - Cancer - Imaging Image-guided radiation therapy |
| ISBN | 3-642-40429-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Radiologic Introduction -- Urologic Introduction -- Medical Oncology Introduction -- Basic Principles: Scope of Prostate Cancer -- MRI of the Prostate -- Benign Disease -- Intraprostatic Cancer -- Localized Extraprostatic Cancer -- Nodal Cancer -- The Treated Gland -- Case Studies with Multimodality Diagnostic Imaging -- Case Studies with Image Guided Treatments -- Medical Oncology and Imaging -- MRI Thermocoupling and Laser Tumor Ablation -- New Robot and Cybernetic Image Guided Technologies -- Long Term Follow-Up -- Minimally Invasive Treatment of Benign Prostate Hypertrophy. |
| Record Nr. | UNINA-9910300068303321 |
| Heidelberg, Germany : , : Springer, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Management of prostate cancer / / Eric A. Klein, J. Stephen Jones, editors
| Management of prostate cancer / / Eric A. Klein, J. Stephen Jones, editors |
| Edizione | [3rd ed.] |
| Pubbl/distr/stampa | New York, : Humana Press, c2013 |
| Descrizione fisica | 1 online resource (425 p.) |
| Disciplina | 616.99/463 |
| Altri autori (Persone) |
KleinEric A. <1955->
JonesJ. Stephen <1960-> |
| Collana | Current clinical urology |
| Soggetto topico |
Prostate - Cancer
Prostate - Cancer - Treatment |
| ISBN |
1-283-61256-9
9786613925015 1-60761-259-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Epidemiology and Risk Factors -- Twenty years and counting: is PSA still useful in 2010? -- Prostate Cancer Screening: A Review of the Evidence with Clinical Practice Implications -- Beyond PSA: Promising New Markers for Prostate Cancer -- Hereditary Prostate Cancer and Genetic Risk -- Prostate Inflammation and Prostate Cancer -- Molecular Progression of Prostate Cancer: Androgens and Estrogens -- The Role of Obesity and Diet in Prostate Cancer -- Prostate Cancer Risk Reduction by Chemoprevention -- Current Issues in Pathologic Evaluation -- Optimum Prostate Biopsy: Technique and Strategies -- The Utility of Nomograms in Routine Clinical Practice -- Active Surveillance Comes of Age -- Focal Therapy: Prostate Hemiablation as the First Historical Treatment Model for Focal Therapy of Early Stage Prostate Cancer -- Contemporary External Beam Radiotherapy -- Surgery, Brachytherapy, or External Beam Radiation for Low and Intermediate-Risk Disease? -- The Role for Radical Prostatectomy in Advanced Prostate Cancer -- Radiation Therapy in the Management of Locally Advanced Prostate Cancer -- Clinical Implications of Measuring Quality-of-Life in Early Stage Prostate Cancer -- Treatment Modalities of Post-Prostatectomy Incontinence: A Historical Perspective As Well As Current Therapy Options -- Management of Biochemical Recurrence After Localized Treatment for Prostate Cancer -- Management of Newly Diagnosed Metastatic Disease -- Pitfalls of Androgen Deprivation Therapy -- Current Management of Castration-resistant Prostate Cancer (CRPC) -- Radiopharmaceuticals and Bone Metastasis. |
| Record Nr. | UNINA-9910438131903321 |
| New York, : Humana Press, c2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Medicare reimbursement for lupron
| Medicare reimbursement for lupron |
| Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2004 |
| Descrizione fisica | 1 online resource (ii, 9 pages) : illustrations |
| Soggetto topico |
Medicare
Prostate - Cancer - Treatment Symptoms - Treatment - United States Pharmaceutical policy - United States Pharmaceutical services insurance - United States Drugs - Prices - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Medicare reimbursement for lupron |
| Record Nr. | UNINA-9910707230803321 |
| [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular exploitation of apoptosis pathways in prostate cancer [[electronic resource] /] / Natasha Kyprianou
| Molecular exploitation of apoptosis pathways in prostate cancer [[electronic resource] /] / Natasha Kyprianou |
| Autore | Kyprianou Natasha |
| Pubbl/distr/stampa | London, : Imperial College Press, 2012 |
| Descrizione fisica | 1 online resource (230 p.) |
| Disciplina | 616.99463 |
| Collana | Molecular medicine and medicinal chemistry |
| Soggetto topico |
Apoptosis
Prostate - Cancer - Treatment |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-66895-4
9786613645883 1-84816-450-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Preface; Chapter 1 Introduction: Prostate Cancer; Chapter 2 The Prostate Gland Dynamics; Chapter 3 Apoptosis Pathways Signaling Execution of Cancer Cells; 3.1 Cell Choices of Life and Death; 3.1.1 "Classic" apoptosis; 3.1.2 Anoikis; 3.2 Caspases: The Apoptosis Executioners in a Therapeutic Setting; 3.3 The Mitochondrion: A Convenient Cell-Killing Platform; 3.4 Cell Surface Death Receptors and the FAS Ligand; 3.5 Meet the BCL-2 Family: Governors of Cell Survival and Death; 3.6 The Transcriptional Controllers; 3.7 The p53 Tumor Suppressor
3.8 PTEN/PI3K/AKT: The Downstream Intracellular Players3.9 The Antagonists of Death: Inhibitors of Apoptosis Proteins (IAPs); 3.10 Apoptosis Signaling in the Endoplasmic Reticulum: A Death Platform for Stress; 3.11 The Tumor Microenvironment: Extracellular Forces Control Intracellular Death Outcomes; 3.11.1 Role of hypoxia; 3.11.2 The key growth factors; 3.11.3 Inflammation; Chapter 4 Androgen Receptor-Mediated Apoptosis: Significance in Development of Castration-Resistant Prostate Cancer; 4.1 The Androgen Receptor (AR); 4.2 Androgen Ablation: The Glory and the Failures 4.3 AR Status in Castration-Resistant Prostate Cancer4.4 AR Interactions with Growth Factor Signaling Leads to Apoptosis; 4.4.1 AR connects with EGF; 4.4.2 AR and IGF interactions; 4.4.3 AR and TGF-β: partners in life and death (of the cell); 4.4.4 AR and FGF interactions; 4.4.5 AR and VEGF: Vascular exchanges for the "road"; 4.4.6 AR and growth factor interplay in the stroma; Chapter 5 Anoikis in Prostate Cancer Metastasis; 5.1 Anoikis Interrupted: Survival of the Homeless (Cells); 5.2 The Integrin Connection; 5.3 Impairing the Route to Angiogenesis; 5.3.1 Doxazosin; 5.3.2 Suramin 5.3.3 Thalidomide5.3.4 Bevacizumab; 5.3.5 SU5416; 5.4 Anoikis and the Tumor Microenvironment: No "Resting" in the Stroma; 5.5 Signaling the "Homeless" State: Intracellular Anoikis Effectors; 5.6 Significance of Apoptosis in Cytoskeleton and Microtubule Targeting; 5.7 Autophagy: The Cellular Benefits of Starving to Death; Chapter 6 Epithelial-Mesenchymal Transition (EMT) in Prostate Cancer Metastasis; Chapter 7 Novel Molecular Therapeutics for Targeting Castration-Resistant Prostate Cancer; 7.1 Therapeutic Targeting of TGF-β Signaling 7.2 Exploitation of Quinazolines: Lifting Anoikis Resistance to Impair Metastasis7.3 Receptor Tyrosine Kinase Targeting; 7.4 Histone Deacetylase Inhibitors (HDACs): Therapeutic Inhibitors; 7.5 Selective Death Action by Cancer-Specific PAR-4 in Prostate Tumors; 7.6 Death Synergy Between Proteosome and Death Receptor Leads to Tumor Regression; 7.7 The SERCA Pump as a Therapeutic Target; 7.8 Endothelin-Receptor Antagonists; 7.9 The Power of Sex Steroid Targeting; Chapter 8 Apoptotic-Based Molecular Markers of Therapeutic Response; Chapter 9 Role of Apoptosis in Prostate Cancer Prevention 9.1 Aspirin and Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
| Record Nr. | UNINA-9910451821703321 |
Kyprianou Natasha
|
||
| London, : Imperial College Press, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular exploitation of apoptosis pathways in prostate cancer [[electronic resource] /] / Natasha Kyprianou
| Molecular exploitation of apoptosis pathways in prostate cancer [[electronic resource] /] / Natasha Kyprianou |
| Autore | Kyprianou Natasha |
| Pubbl/distr/stampa | London, : Imperial College Press, 2012 |
| Descrizione fisica | 1 online resource (230 p.) |
| Disciplina | 616.99463 |
| Collana | Molecular medicine and medicinal chemistry |
| Soggetto topico |
Apoptosis
Prostate - Cancer - Treatment |
| ISBN |
1-280-66895-4
9786613645883 1-84816-450-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Preface; Chapter 1 Introduction: Prostate Cancer; Chapter 2 The Prostate Gland Dynamics; Chapter 3 Apoptosis Pathways Signaling Execution of Cancer Cells; 3.1 Cell Choices of Life and Death; 3.1.1 "Classic" apoptosis; 3.1.2 Anoikis; 3.2 Caspases: The Apoptosis Executioners in a Therapeutic Setting; 3.3 The Mitochondrion: A Convenient Cell-Killing Platform; 3.4 Cell Surface Death Receptors and the FAS Ligand; 3.5 Meet the BCL-2 Family: Governors of Cell Survival and Death; 3.6 The Transcriptional Controllers; 3.7 The p53 Tumor Suppressor
3.8 PTEN/PI3K/AKT: The Downstream Intracellular Players3.9 The Antagonists of Death: Inhibitors of Apoptosis Proteins (IAPs); 3.10 Apoptosis Signaling in the Endoplasmic Reticulum: A Death Platform for Stress; 3.11 The Tumor Microenvironment: Extracellular Forces Control Intracellular Death Outcomes; 3.11.1 Role of hypoxia; 3.11.2 The key growth factors; 3.11.3 Inflammation; Chapter 4 Androgen Receptor-Mediated Apoptosis: Significance in Development of Castration-Resistant Prostate Cancer; 4.1 The Androgen Receptor (AR); 4.2 Androgen Ablation: The Glory and the Failures 4.3 AR Status in Castration-Resistant Prostate Cancer4.4 AR Interactions with Growth Factor Signaling Leads to Apoptosis; 4.4.1 AR connects with EGF; 4.4.2 AR and IGF interactions; 4.4.3 AR and TGF-β: partners in life and death (of the cell); 4.4.4 AR and FGF interactions; 4.4.5 AR and VEGF: Vascular exchanges for the "road"; 4.4.6 AR and growth factor interplay in the stroma; Chapter 5 Anoikis in Prostate Cancer Metastasis; 5.1 Anoikis Interrupted: Survival of the Homeless (Cells); 5.2 The Integrin Connection; 5.3 Impairing the Route to Angiogenesis; 5.3.1 Doxazosin; 5.3.2 Suramin 5.3.3 Thalidomide5.3.4 Bevacizumab; 5.3.5 SU5416; 5.4 Anoikis and the Tumor Microenvironment: No "Resting" in the Stroma; 5.5 Signaling the "Homeless" State: Intracellular Anoikis Effectors; 5.6 Significance of Apoptosis in Cytoskeleton and Microtubule Targeting; 5.7 Autophagy: The Cellular Benefits of Starving to Death; Chapter 6 Epithelial-Mesenchymal Transition (EMT) in Prostate Cancer Metastasis; Chapter 7 Novel Molecular Therapeutics for Targeting Castration-Resistant Prostate Cancer; 7.1 Therapeutic Targeting of TGF-β Signaling 7.2 Exploitation of Quinazolines: Lifting Anoikis Resistance to Impair Metastasis7.3 Receptor Tyrosine Kinase Targeting; 7.4 Histone Deacetylase Inhibitors (HDACs): Therapeutic Inhibitors; 7.5 Selective Death Action by Cancer-Specific PAR-4 in Prostate Tumors; 7.6 Death Synergy Between Proteosome and Death Receptor Leads to Tumor Regression; 7.7 The SERCA Pump as a Therapeutic Target; 7.8 Endothelin-Receptor Antagonists; 7.9 The Power of Sex Steroid Targeting; Chapter 8 Apoptotic-Based Molecular Markers of Therapeutic Response; Chapter 9 Role of Apoptosis in Prostate Cancer Prevention 9.1 Aspirin and Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
| Record Nr. | UNINA-9910779279003321 |
|
Kyprianou Natasha
|
||
| London, : Imperial College Press, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular exploitation of apoptosis pathways in prostate cancer / / Natasha Kyprianou
| Molecular exploitation of apoptosis pathways in prostate cancer / / Natasha Kyprianou |
| Autore | Kyprianou Natasha |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | London, : Imperial College Press, 2012 |
| Descrizione fisica | 1 online resource (230 p.) |
| Disciplina | 616.99463 |
| Collana | Molecular medicine and medicinal chemistry |
| Soggetto topico |
Apoptosis
Prostate - Cancer - Treatment |
| ISBN |
1-280-66895-4
9786613645883 1-84816-450-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Preface; Chapter 1 Introduction: Prostate Cancer; Chapter 2 The Prostate Gland Dynamics; Chapter 3 Apoptosis Pathways Signaling Execution of Cancer Cells; 3.1 Cell Choices of Life and Death; 3.1.1 "Classic" apoptosis; 3.1.2 Anoikis; 3.2 Caspases: The Apoptosis Executioners in a Therapeutic Setting; 3.3 The Mitochondrion: A Convenient Cell-Killing Platform; 3.4 Cell Surface Death Receptors and the FAS Ligand; 3.5 Meet the BCL-2 Family: Governors of Cell Survival and Death; 3.6 The Transcriptional Controllers; 3.7 The p53 Tumor Suppressor
3.8 PTEN/PI3K/AKT: The Downstream Intracellular Players3.9 The Antagonists of Death: Inhibitors of Apoptosis Proteins (IAPs); 3.10 Apoptosis Signaling in the Endoplasmic Reticulum: A Death Platform for Stress; 3.11 The Tumor Microenvironment: Extracellular Forces Control Intracellular Death Outcomes; 3.11.1 Role of hypoxia; 3.11.2 The key growth factors; 3.11.3 Inflammation; Chapter 4 Androgen Receptor-Mediated Apoptosis: Significance in Development of Castration-Resistant Prostate Cancer; 4.1 The Androgen Receptor (AR); 4.2 Androgen Ablation: The Glory and the Failures 4.3 AR Status in Castration-Resistant Prostate Cancer4.4 AR Interactions with Growth Factor Signaling Leads to Apoptosis; 4.4.1 AR connects with EGF; 4.4.2 AR and IGF interactions; 4.4.3 AR and TGF-β: partners in life and death (of the cell); 4.4.4 AR and FGF interactions; 4.4.5 AR and VEGF: Vascular exchanges for the "road"; 4.4.6 AR and growth factor interplay in the stroma; Chapter 5 Anoikis in Prostate Cancer Metastasis; 5.1 Anoikis Interrupted: Survival of the Homeless (Cells); 5.2 The Integrin Connection; 5.3 Impairing the Route to Angiogenesis; 5.3.1 Doxazosin; 5.3.2 Suramin 5.3.3 Thalidomide5.3.4 Bevacizumab; 5.3.5 SU5416; 5.4 Anoikis and the Tumor Microenvironment: No "Resting" in the Stroma; 5.5 Signaling the "Homeless" State: Intracellular Anoikis Effectors; 5.6 Significance of Apoptosis in Cytoskeleton and Microtubule Targeting; 5.7 Autophagy: The Cellular Benefits of Starving to Death; Chapter 6 Epithelial-Mesenchymal Transition (EMT) in Prostate Cancer Metastasis; Chapter 7 Novel Molecular Therapeutics for Targeting Castration-Resistant Prostate Cancer; 7.1 Therapeutic Targeting of TGF-β Signaling 7.2 Exploitation of Quinazolines: Lifting Anoikis Resistance to Impair Metastasis7.3 Receptor Tyrosine Kinase Targeting; 7.4 Histone Deacetylase Inhibitors (HDACs): Therapeutic Inhibitors; 7.5 Selective Death Action by Cancer-Specific PAR-4 in Prostate Tumors; 7.6 Death Synergy Between Proteosome and Death Receptor Leads to Tumor Regression; 7.7 The SERCA Pump as a Therapeutic Target; 7.8 Endothelin-Receptor Antagonists; 7.9 The Power of Sex Steroid Targeting; Chapter 8 Apoptotic-Based Molecular Markers of Therapeutic Response; Chapter 9 Role of Apoptosis in Prostate Cancer Prevention 9.1 Aspirin and Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
| Record Nr. | UNINA-9910809645803321 |
|
Kyprianou Natasha
|
||
| London, : Imperial College Press, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Prostate cancer : leading-edge diagnostic procedures and treatments / / edited by Ravinder Mohan
| Prostate cancer : leading-edge diagnostic procedures and treatments / / edited by Ravinder Mohan |
| Pubbl/distr/stampa | Rijeka, Croatia : , : InTech, , [2016] |
| Descrizione fisica | 1 online resource (258 pages) : illustrations |
| Disciplina | 616.99463 |
| Soggetto topico | Prostate - Cancer - Treatment |
| ISBN |
953-51-7313-8
953-51-2645-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
Prostate cancer
Prostate Cancer - Leading-edge Diagnostic Procedures and Treatments |
| Record Nr. | UNINA-9910169215103321 |
| Rijeka, Croatia : , : InTech, , [2016] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
